MRI-guided ablation improves outcomes for younger AFib patients, study shows

Younger atrial fibrillation (AFib) patients are most likely to benefit from more personalized, MRI-guided ablation treatments to correct irregular heart rhythms, according to a new artificial intelligence-guided analysis of results from the DECAAF II trial, one of the largest global studies of treatments for heart arrhythmias.

Xencor Inc Files Patent for Bispecific Antibody to Treat GPC3-Associated Cancers

Share this article According to GlobalData’s company profile on Xencor, Personalized cancer vaccines was a key innovation area identified from patents. Xencor‘s grant share as

April 4, 2024

The Senate health committee looks into its first subpoena in 40 years

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. We’re seeing some rays

January 19, 2024

Updated atrial fibrillation guidelines focus on risk management and patient-centered care

The 2024 ESC Guidelines for the management of atrial fibrillation, developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS), contain a number of

August 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.